| (USD) | May 2026 | Y/Y change |
|---|---|---|
| Revenue | 9.04M | — |
| Operating expense | — | — |
| Net income | -89.53M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NRIX returned +163.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +40.9% |
| 1 year | +163.5% |
| 5 years | -17.0% |
| All-time high | $42.62 (Nov 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NRIX would be worth today ›No. Nurix Therapeutics, Inc. has not paid a dividend in the past 12 months.
Nurix Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol NRIX.
Nurix Therapeutics, Inc. is part of the Healthcare sector.
Nurix Therapeutics, Inc. has a market cap of 2.77B USD, based on the latest quote.
Nurix Therapeutics, Inc. is expected to report earnings around Oct 8, 2026. That date is an estimate and has not been confirmed by the company.
